Chronic Therapy with Sucroferric Oxyhydroxide Does Not Affect Iron and Anemia Markers in Dialysis Patients
Sign Up to like & getrecommendations! Published in 2020 at "Blood Purification"
DOI: 10.1159/000505432
Abstract: Introduction: Sucroferric oxyhydroxide (SOH) is an iron-based phosphate binder (PB), and its use has been widely expanded since its initial approval in 2014. Based on the existing data, however, it remains yet unclear whether its… read more here.
Keywords: anemia; sucroferric oxyhydroxide; chronic therapy; iron ... See more keywords